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Determination of enantiomeric excess (ee) in chiral compounds is a key step in the 
development of chiral catalyst auxiliaries and chiral drugs. Here, we describe a sensitive 
and robust fluorescence-based assay for the determination of ee in mixtures of enantiomers 
of 1,2- and 1,3-diols, chiral amines, amino alcohols, and amino acid-esters. The method is 
based on the dynamic self-assembly of commercially available chiral amines, 2-
formylphenylboronic acid, and chiral diols in acetonitrile to form diastereomeric 
fluorescent complexes. Each analyte enantiomer gives rise to a different diastereomer with 
a distinct fluorescence wavelength and intensity originating from the enantiopure 
fluorescent ligands. In this assay, enantiomers of amines and amine derivatives assemble 
with diol-type ligands containing bi-naphthol moiety (BINOL and VANOL), while diol 
enantiomers form complex with the enantiopure amine-type fluorescent ligand 
tryptophanol. This differential fluorescence can be utilized to determine the amount of 
each enantiomer in the mixture with errors below 1% ee. This method allows for the real-
time evaluation of enantiomeric/diastereomeric excess (ee/de) and product yield of crude 
asymmetric reaction products in a high-throughput fashion. The only processes involved in 
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this protocol are high-throughput liquid dispensing of three components into 384-well 
plates and recording the fluorescence using automatic plate reader. Emergence of such 
high throughput approaches allows scaling up the screening of combinatorial libraries, and 
together with parallel synthesis creates a robust platform for discovering chiral catalysts or 
auxiliaries for asymmetric transformations and chiral drug development. The procedure 
takes 3-4 hours to run and requires 10–20 ng of the substrate per well. Our fluorescence-
based assay offers distinct advantages over existing traditional methods as it is not sensitive 
to the presence of common additives or impurities as well as unreacted/incomplete utilized 
reagents and catalysts. 
 
INTRODUCTION 
Separation of enantiomers has become a significant research area in analytical chemistry owing to 
its impact on chemical, pharmaceutical, industries, and biotechnology. Traditional methods for 
determination of enantiomeric purity such as 1H- and 19F- NMR spectroscopy,1–4 circular 
dichroism (CD),5–7 and chiral separation techniques such as chiral-phase high performance liquid 
chromatography (HPLC),8 HPLC coupled with circular dichroism (HPLC-CD),9–11 or chiral gas 
chromatography (GC)12,13 and capillary electrophoresis (CE),14 are the reliable standard methods 
that are most used for the separation and determination of enantiomers.14 However, these 
techniques are better suited for serial analyses. This is in contrast to the needs of combinatorial 
chemistry and parallel synthesis which require samples to be simultaneously analyzed in a real-
time on a large scale, which require high-throughput platform for analysis.15–17  
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Kubo et al. were among the pioneers in the development of enantioselective optical sensors for 
ee; in their initial work, they described screening of amines using derivatized calixarenes in 
ethanol.18,19 Later a number of research groups, such as Anslyn et al,20–23 Wolf et al,24–27 James et 
al,28–30 among other groups have developed high-throughput screening (HTS) methods for real-
time analysis of enantiomers, contributing to the development and optimization efforts in the 
discovery of efficient catalysts and conditions for asymmetric reactions.14  
Our research team has developed a versatile fluorescence-based assay for determination of ee in 
mixtures of enantiomers of 1,2- and 1,3-diols, amines, amino acid esters, and amino alcohols  
(Figure 1).31–33 The method is based on dynamic self-assembly of commercially available, 
enantiopure, yet inexpensive fluorescent ligands, linked by 2-formylphenylboronic acid, with 
chiral analytes to form diastereomeric complexes (Figure 2). Specifically, fluorescent (S)-(+)-1,1′-
bi(2-naphthol) (BINOL) and (S)-3,3′-diphenyl-2,2′-bi(1-naphthol)(VANOL) ligands were utilized 
as a reporters with amine-type analytes, and enantiopure L-tryptophanol was used in a complex 
assembly for 1,2 and 1,3 chiral diol analytes. Each analyte enantiomer self-assembles through the 
2-formylphenylboronic acid linker with the associated fluorescence reporter and creates a highly 
geometry-sensitive diastereomeric complex with unique fluorescence signatures. In case of diol 
and amino alcohol enantiomers, their diastereomeric complexes can be tracked by not only 





Figure 1. Schematic of the enantiomeric excess determination process and experimental workflow. All 
components of the self-assembly are commercially available and are used without further purification. (i) Three-
component derivatization reaction between 1 equiv. of the chiral diol, 1 equiv. of 2-formylphenylboronic acid, 1 equiv. 
of chiral amine (ii) results in quantitative complexation that yields a mixture of structurally rigid fluorescent 
diastereomeric imino/oxazolidine-boronate esters. (iii) The assembly fluorescence is clearly observable upon 100 
times dilution in the microplate well. (iv) The adaptation of the three-component self-assembly derivatization to a 
384-well microplate format and use of a plate-reader to detect the fluorescence emission, allows to minimize volume 
and molar amount analyte required for a measurable fluorescence signal. (v) The fluorescence response pattern is 
acquired in a form of X vs Y data matrix. The linear/nonlinear regression enables finding the coefficients of polynomial 
equation that are a best linear fit to a set of X,Y data corresponding to ee and FI of the standards. (vi) Interpolation of 
a standard curve enables to simultaneously predict ee values (X) for measured FI (Y) of multiple unknowns. 
In this protocol a signal output is used to determine the enantiomeric excess (ee) in the mixture 
with the errors below 1% ee (Figure 3, Procedure 1). This method can be extended to determining 
enantiomeric/diastereomeric excess (ee/de) and product concentration (yield) of chiral products in 
real time using a high-throughput platform (Procedure 2). Moreover, selection of different diol-
type ligands allows for use of the same method for determination of ee in the mixtures of chiral 
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amines, amino alcohols, amino acid-esters, and amine-type ligands for determination of 
enantiomeric purity in the mixtures of chiral diols and sugars. The only techniques involved in the 
method are high-throughput liquid dispensing of three components into 384-well plate and 
recording the fluorescence using an automatic plate reader. Our fluorescence-based assay offers 
some distinct advantages over existing traditional methods such as cHPLC or NMR since it is not 
sensitive to the presence of any common additives or impurities or to unreacted/incomplete utilized 
reagents and catalysts. Furthermore, the proposed method is uniquely suitable for high-throughput 
analysis using simple fluorescence readers and microplates and is applicable to combinatorial 
chemistry and parallel synthesis that require simultaneous analysis of a large number of samples. 
Assay Principle  
This protocol is an extension of the  simple three-component chiral derivatization protocol 
for determining the enantiopurity of chiral primary amines34,35, and diols2,3 by 1H NMR 
spectroscopic analysis that was described first by T. D. James and S. D. Bull. The method is based 





Figure 2. Components and self-assembly mechanisms use for ee determination in chiral amines and amine-
derivatives. Left: Chiral derivatization protocol utilizing the self-assembly of chiral diol-type fluorophores BINOL 
and VANOL, with 2-FPBA, and a chiral amine or amine derivative.31,32,40 Depending on the size and structure of the 
chiral amine/amine derivative, the interaction between the chiral ligand and amine, and an architecture of the 
stereocontrolled sites results in either recovery of partly quenched or further quenching of the fluorescence. Right: 
Range of chiral amines, amino alcohols, and amino acid esters successfully derivatized to afford fluorescent 
diastereomeric imino/oxazolidine-boronate esters that show highly variable enantiomer-induced fluorescence.  
We developed a fluorescence-based three-component chiral derivatization protocol that 
utilizes the self-assembly of 1 equiv. of a chiral diol, with 1 equiv. of 2-formylphenylboronic acid 
(2-FPBA), and 1 equiv. of a chiral amine or amine derivative. The assembled product is either an 
iminoboronate with BINOL or VANOL diol ligands as the fluorophore (Figure 2) or an 
oxazolidine boronate ester (Figure 4) with L-tryptophanol amine ligand as the fluorophore. Each 
diastereomer has a distinct analyte-enantiomer induced fluorescence signal. This differential 
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fluorescence signal is driven by different post-assembly geometries of the possible diastereomers, 
which are also related to the stability of the diastereomeric complexes in acetonitrile. The more 
stable diastereomer shows greater fluorescence intensity change and typically favors fluorescence 
amplification as opposed to quenching of the opposite less stable diastereomer. The complex 
stability with amino alcohols results in considerable shift of fluorescence maxima due to formation 
of oxazolidine ring (Figure 4) and overall increase of structural rigidity. Such changes and further 
equilibrium are reflected by differential fluorescence which enable the determination of the nature, 
absolute configuration, and enantiomeric purity of the chiral analytes (see Procedure 1). 
Due to the high association constant of this self-assembly, maximum fluorescence change 
is observed when a 1:1:1 stoichiometry of the three components is reached followed by saturation 
of fluorescence signal (plateau). All fluorescence titrations a show well-resolved horizontal plateau 
region without any signal fluctuation after reaching 1 molar equivalent of analyte and were tested 
up to 5 molar equivalents. The use of excess of analyte would not have any effect on the protocol 
accuracy and can be used to simplify reactions sampling if there is no intention to determine the 
yield. 
In experiments to determine the effects of additives such as water, alcohols, and other 
compounds to the mixture showed that the additives destabilize the less stable diastereomer 
resulting in an a higher difference between the diastereomeric iminoboronates and therefore better 
discrimination between the enantiomers.32  
The most straightforward method of obtaining absolute configuration and ee of chiral 
analytes from fluorescence intensity (FI) acquired with high-throughput assay is by utilizing a 
standard curve method with linear/nonlinear data fitting (Figure 3 and Figure 5).36 The developed 
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protocol allows for the accurate quantitative determination of the ee of chiral amines, amino acid 
esters, amino alcohols, or diols with errors of just 1%. 
 
Figure 3. Standard curve from maximum fluorescence intensity of BINOL fluorescence at 355nm and VANOL 
at 375 nm. Monitoring enantiomeric purity of Valine methyl ester in Figure 3a and cis-1-amino-2-indanol (AID) 
Figure 3b using high-throughput fluorescence assay. All standards (black squares) and validation samples (red and 
blue circles) measured in a set of 24 repetitions. Student’s T-test is performed in order to examine the difference 
(standard deviation) between data within the set of 24 repetitions for each sample and exclude 4 outlying data points. 
Each data point shown on a graph as an average value computed from 20 independent measurements (repetitions). 
Graphical representations of the variability of data shown on graphs as the error bars to indicate the standard deviation 
in the reported measurement. Due to coefficient of variation (CV) being below 4% for all performed experiments the 
error bar for most data points located within the corresponding mean point on the graph. Graphs of enantiomeric 
excess-induced fluorescence change are fitted with linear fit equation.  
When the analyte concentration is unknown then an extended/training data set 
comprising range from -100 to +100 % ee should be prepared at several different total 
concentration of analyte for each receptor-premix (Figure 6, Procedure 2). All receptors 
(BINOL-FPBA, VANOL-FPBA, L-tryptophanol-FPBA, at 1:1 molar ratio) respond to both the 
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change in concentration and ee of the analyte of interest. This protocol may also be adapted for 
the simultaneous detection of yield, enantiomeric excess (ee), and diastereomeric excess (de) of 
crude chiral products using an artificial neural network (ANN) without the need of work-up and 
product isolation.33 Fluorescence data for different concentrations and ee values of the analytes 
are collected in a 384-well plate (training plate) and the values obtained are used to train an 
ANN. The fluorescence data from unknowns/analytes are imported into a computer, analyzed 
with the trained ANN, and the values of ee and the total concentrations for the unknowns are 
exported. The comparison of the results obtained for crude and crystallized samples of Noyori 
asymmetric transfer hydrogenation of benzils shows that our method is not sensitive to traces of 
chiral catalysts or possible reaction additives and may be applied to the determination of ee in 
crude product mixtures. We have also tested sensitivity of the assay to the presence of meso-
hydrobenzoin. It was found, that the method is not sensitive up to 7% of meso-form.  
Assay for the Determination of Enantiomeric Purity of Amines, Amino Acid Esters, and 
Amino Alcohols 
Differential amine enantiomers-induced fluorescence arises from the iminoboronates 
comprising 2-FPBA, the chiral amines under analysis, and different sized enantiopure fluorescent 
diol-type ligands (S)-(+)-1,1′-bi(2-naphthol) (BINOL) and (S)-3,3′-diphenyl-2,2′-bi(1-
naphthol)(VANOL)37–39 (Figure 2). Each analyte forms a complex with both BINOL and VANOL. 
The complexes formed between the chiral amine and BINOL are approximately equally stable. 
VANOL, however, is a lot bigger than BINOL and the steric effects mean that one of stereoisomers 
is going to be a lot more stable than the other. In choosing which fluorescent diol ligand to use, it 
is also worth bearing in mind that the size of the ligand also has an effect on the magnitude of 
fluorescence signal emitted.31,32,40 Enantioselectivity for any potential chiral analyte can be 
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achieved by finding an appropriate size of enantiopure chiral receptor (Figure 3). Large variety of 
chiral fluorescent diols of different sizes are available for screening including, but not limited to 
(S)-3,3′-Di-9-anthracenyl-1,1′-bi-2-naphthol (CAS Number 361342-50-9), (S)-(–)-3-3′-Bis(3,5-
bis(trifluoromethyl)phenyl)-1,1′-bi-2-naphthol (CAS Number 849939-13-5), (S)-(+)-3,3′-Bis(3,5-
dimethylphenyl)-5,5′,6,6′,7,7′,8,8′-octahydro-1,1′-bi-2-naphthol, (S)-3,3′-Di-9-phenanthrenyl-
1,1′-bi-2-naphthol, (S)-(–)-3,3′-Bis(triphenylsilyl)-1,1′-bi-2-naphthol. These commercially 
available chiral building blocks containing a 1,2- or 1,3-diol moiety can be bound to the 2-
formylphenylboronic acid and form diastereomeric complexes with amine containing chiral 
analytes that have large optical differences for enantiomeric analytes, thereby allowing to make 
accurate assays. Such adaptive feature makes the protocols more amenable to adoption by other 
researchers.  
User can find best suitable receptor and concentration conditions as preparatory work 
required before screening by the following procedure. These steps are quick because they involve 
well plate screening and lead to an analyte-specific assay: 
1. By using traditional fluorescence titrations and standard binding isotherms or well plate 
screen, proper concentrations (recommended concentration is 40 µM) for combining the chiral 
fluorescent diol, 2-formylphenylboronic acid and chiral analyte must be determined and the 1:1:1 
stoichiometry must be confirmed.  
2. The chiral fluorescent receptors and enantiomers of chiral analytes are then screened in 
a well plate to reveal the best chiral receptor complex with largest differences in fluorescent signal 
for reporting the ee (Figure 7) of a chiral target diastereomers (largest ∆ of diastereomers).There 
is substantial variation between the intensity/wavelength of fluorescence emitted by the different 
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diastereomeric boronate esters. Upon assembly with amines fluorescent ligands show a high 
degree of signal change compare to the free state (without being bound to 2-FPBA and amine-
analyte) and high association constants (Ka ≈ 10
6). The esters of amines and amino acids have a 
relatively low degree of fluorescence quenching, due to their small size and lower binding affinity 
(Ka ≈ 10
5). Amino alcohols display ratiometric changes in fluorescence due to formation of 
oxazolidine boronate esters41 which possess higher rigidity, compared to iminoboronates, and the 
introduction of another chiral center causes a shift and an amplification of the observed 
fluorescence signal.32 All types of analytes show saturation of fluorescent ligand signal change at 
the 1:1:1 molar ratio. For our experiments we used an optimal concentration of 40 µM for 
fluorescent ligands BINOL/VANOL and the linker 2-FPBA. The quantity of chiral analyte can be 
simply determined by adding measured increments of it until the final concentration of 40 µM (or 
1 molar equivalent) is reached followed by immediate saturation of fluorescence emitted by the 
bound ligand.  
The formation of the iminoboronates requires dynamic covalent bond formation.42 
Destabilization of the formed diastereomeric iminoboronates improves the resolution of the 
enantiomers of amines, or amine derivatives. Addition of water <10 % or other common additives 
(carboxylic acids such as citric acid, or alcohols such as ethylene glycol) results in a change in the 
esterification equilibrium and destabilizes the formation of one of the two diastereomeric 
iminoboronates more than the other, effectively creating a significant difference in recognition of 
the amine enantiomers. Importantly, this method is not dramatically sensitive to potential 
impurities and can be applied to the analysis of chiral amines/amine derivatives in a complex 
environment including crude reaction products from asymmetric reactions.33 
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We performed the assay under ambient conditions using two diol-type fluorophores 
BINOL and VANOL (Figure 3, Supplementary Figure 1, Supplementary Figure 2). First, it is 
necessary to calibrate the system for up to the two extremes of ee-induced fluorescence by using 
mixtures of standards that range from -100% ee to +100% ee). Validation samples are prepared 
and measured in the same plate as the samples with unknown ee. The background fluorescence is 
generally 5-10% of the maximum fluorescence. The assay measures the total fluorescence as a 
function of enantiomeric composition (fluorescence intensity data for valine methyl ester and cis-
1-amino-2-indanol are shown in Supplementary Data 1 and Supplementary Data 2 respectively). 
We obtained reliable results (Table1) using a set of 24 repetitions. In this context (Figure 3,a) a 
total of 23 independent Valine samples or observations including 15 different ee values (100, 90, 
80, 70, 50, 30, 10, 0, -10, -30, -50, -70, -80, -90, -100, %ee) used for standard curve calibration 
and 8 unknown samples analyzed with BINOL-based system and 23 independent Valine 
observations including 15 different ee values (100, 90, 80, 70, 50, 30, 10, 0, -10, -30, -50, -70, -
80, -90, -100, %ee) used for standard curve calibration and 8 unknown samples analyzed with 
VANOL-based system. Total number of observations is 46. For each sample, we also performed 
24 technical replicates to prove the assay’s reproducibility; and to minimize the effect of human 
error on the result. This means that a total amount of 1104 individual experiments are performed 
(46 observations X 24 technical repetitions). For our graphs we calculate the average between the 
technical replicates, standard deviation, and coefficient of variation. 
For all tested analytes (Figure 2) (S)-BINOL gives a smaller magnitude of fluorescence 
change between diastereomers (the ∆ of diastereomers) compared to the more fluorescent (S)-
VANOL, therefore, the use of (S)-VANOL is recommended. We would recommend the use of (S)-
VANOL for amines, amino alcohols, and amino acids because in most tested cases the use of 
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single VANOL-based system was enough to achieve sufficient discriminatory power of the assay. 
BINOL can be added as a second system to increase dimensionality of a data set and improve 
discriminatory potential of particular assay. 
 
Table 1 The results of ee determination protocol with linear regression fitting function. 
entry BINOL VANOL 


















1 R 75 R 76 R 80 R 82 
2 R 50 R 52 R 70 R 71 
3 rac 0 S -2 R 50 R 50 
4 S -15 S -13 R 40 R 38 
5 S -25 S -27 S -15 S -16 
6 S -35 S -37 S -20 S -22 
7 S -55 S -56 S -30 S -32 
8 S -90 S -89 S -40 S -39 
cis-AID BINOL VANOL 
9 R,S 60 R,S 62 S,R -50 S,R -50 
10 R,S 25 R,S 28 S,R -35 S,R -32 
11 R,S 5 R,S 6 S,R -25 S,R -24 
12 S,R -30 S,R -27 R,S 10 R,S 10 
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13 S,R -95 S,R -94 R,S 35 R,S 35 
14     R,S 55 R,S 56 
15     R,S 85 R,S 84 
 
Assay for the Determination of Enantiomeric Purity of 1,2 and 1,3-Diols 
Stereodynamic self-assemblies for determination of the absolute configuration and 
enantiomeric composition of chiral 1,2- or 1,3-diol are described in the protocol (Figure 4). This 
approach utilizes a self-assembled oxazolidine ester formed as a product by dynamic covalent self-
assembly of a chiral diol with an enantiopure fluorescent amino alcohol tryptophanol and 2-
formylphenylboronic acid (Figure 4).33 The tryptophanol possesses bright fluorescence and forms 
rigid oxazolidine boronate esters upon complexation with FPBA and a chiral diol. The resulting 
diastereomeric boronates display a distinctive enantiomer-induced fluorescence change allowing 
for the ee determination of molecules containing a 1,2- or 1,3-diol moiety. 
Significant difference in the arrangement of the diastereomeric complexes is induced by 
the geometry/chirality of the diol and causes a dramatic change in the magnitude of the 
fluorescence signal. We evaluated the protocol using various enantiomeric diols clearly 
demonstrating that different enantiomers of diols always either quench or amplify the fluorescence 




Figure 4. Components and self-assembly mechanisms use for ee determination in chiral diols and sugars. Left: 
The concept of dynamic covalent self-assembly for enantiomeric excess determination of chiral diols: 1,2- or 1,3-diols 
self-assemble with an enantiomerically pure fluorescent tryptophanol reporter and 2-formylphenylboronic acid. Right: 
Examples of chiral diols that display strong enantiomer-induced fluorescence signal upon formation of diastereomeric 
oxazolidine boronate esters.  
We performed the protocol for the determination of enantiomeric purity of chiral diols by 
recording the fluorescence intensities utilizing a conventional microplate reader with total volume 
120 µL in a 384-well density plate. The resulting standard curves are defined as a function of FI 
of L-tryptophanol (using just one channel: λexc=280 nm / λem=330) nm plotted on the Y-axis against 
various ee of standards along the X-axis (Figure 5).  
The absolute configuration and ee of unknowns (i.e., the chiral analytes of interest or 
products of asymmetric reactions) were determined by interpolation of their fluorescence readings 
on the standard curve. Linear regression is well suited to fit the obtained standard curve with linear 
ee-dependency (See Supplementary Figure 3). To ensure reproducibility, the assay must be done 
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over a set of at least 3 technical replicates for each standard (mixtures with known ee composition 
used for standard curve calibration) and each unknown sample. Typical experiments include 
standards spanning -100 to +100% enantiomeric excess range to generate a standard curve. To 
maximize sensitivity, it is recommended to choose small ee step between standards (especially in 
the range of expected values as shown on Supplementary Figure 4). The number of points on the 
standard curve can be increased or decreased as desired, and as few as three points (-100% ee, rac-
mix, +100% ee) can be used when the target asymmetric reaction or sample are well characterized 
(see fluorescence intensity data set for atorvastatin in Supplementary Data 3 and in Supplementary 
Data 4 for hydrobenzoin). If the concentration of analyte material is not known and must be 
determined, the extended protocol comprising set of standard curves of different total 
concentrations (Figure 6) must be applied and subjected to ANN for analysis. To ensure predictive 
ability of the generated models we always recommend to split created data sets for the “training 
data set” to create and calibrate the model and “validation data set” which would contain samples 
of known ee and concentration but used as an “artificial unknowns” and attest model as actual vs 




Figure 5. Examples of the use of protocol for determination of enantiomeric purity of diols and their absolute 
configuration. Left: Standard curve obtained from L-tryptophanol-2-FPBA assembly (1:1, 40 μM) with atorvastatin 
enantiomers at various ee. 14 samples of unknown enantiomeric composition of atorvastatin were simultaneously 
correctly interpolated from the curve using linear regression model (Supplementary Figure 3). Right: Standard curve 
generated from hydrobenzoin samples with various enantiomeric composition (ee range from 100% (R,R)-
hydrobenzoin to 100% (S,S)-hydrobenzoin). Six unknown asymmetric reaction samples, their absolute configuration 
and ee were simultaneously correctly interpolated from the graph using linear regression model (Supplementary Figure 
4). Each assay solution contains a 1:1:1 equiv. ratio and 40 μM total concentration of L-tryptophanol reporter, 2-
formylphenylboronic acid, and enantiomeric mixture of diols under analysis. We employ measurements of 24 
repetitions in each standard and unknowns to construct these curves. However, the number of repetitions can be 
substantially reduced to 8 or 4 as proposed in the procedure section. Student’s T-test is performed in order to examine 
the difference (standard deviation) between data within the set of 24 repetitions for each sample and exclude 4 outlying 
data points. Each data point shown on a graph as an average value computed from 20 independent measurements 
(repetitions). Graphical representations of the variability of data shown on graphs as the error bars to indicate the 
standard deviation in the reported measurement. Due to coefficient of variation (CV) being below 4% for all performed 
experiments, the error bar for most data points is located within the corresponding mean point on the graph. Graphs 
are fitted with a linear fit equation 
We assessed the protocol for the systematic examination of crude products of asymmetric 
reactions in real time. The products of a Noyori asymmetric transfer hydrogenation of benzils 
catalyzed by RuCl[(R,R)-Tsdpen](p-cymene) or RuCl[(S,S)- Tsdpen](p-cymene) catalysts with a 
formic acid/triethylamine mixture were evaluated. The reaction quantitatively afforded S,S- and 
R,R-hydrobenzoin with various enantiomeric purity allowing for perfect absolute configuration 
and ee determination of small amounts (<1 mg) in the crude form (without product crystallization). 
We generated a calibration dataset (Supplementary Data 4) using pure enantiomers of 
hydrobenzoin (Fig. 5, right). The resulting multivariate data set was analyzed by Support Vector 
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Machine and 29 data points from the calibration set were used to develop/calibrate the linear 
regression model (black on Figure 5, right).  
Next, the validated model was used to simultaneously determine the ee in the six entries of 
unknown ee which were obtained from the parallel Noyori reactions. First two samples were 
prepared using RuCl[(S,S)-Tsdpen](p-cymene) catalysts, while next two samples using 
RuCl[(R,R)-Tsdpen](p-cymene). As expected, S,S-catalyst gave a pure (R,R)-hydrobenzoin and the 
R,R-catalyst gave (S,S)-hydrobenzoin respectively. The ee was determined as 95.4% ee for the 
crude product and 99.5% ee for the recrystallized sample. Result for the second pair of samples 
show 98.3% ee for the crude mixture and 99.7% ee for the recrystallized sample, which is in perfect 
agreement with the 1H NMR results and literature values. Third pair of unknowns was prepared 
using a 1:1 mixture of RuCl[(S,S)-Tsdpen](p-cymene) catalysts and RuCl[(R,R)-Tsdpen](p-
cymene) catalysts, respectively, and gave a small excess of (R,R)-hydrobenzoin. The 
corresponding ee values were predicted as 3.7% ee for the crude product and 2.8% ee for the 
recrystallized part of the reaction mixture. To perform the ee assignment using the present method 
in 20 technical replicates per entry takes < 1 min. Each well\experiment requires only nanograms 
of the substrate. The comparison of the results obtained for crude and crystallized samples shows 
that this method is not sensitive to traces of catalysts or reaction additives and may be applied for 
the high-throughput screening of ee in crude product mixtures of parallel asymmetric synthesis. 
Note that, the product of incomplete reaction comprising only one reduced carbonyl, is 
unable to interfere with the complexation between boronic acid and tryptophanol and such sample 
was used as a control sample. We concluded that the method is not dramatically sensitive up to 
≈7% of meso-form in the sample of an analyzed chiral diol. Beyond this value, new calibration 
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sets comprising different amount of meso-form must be developed, and consequently, the method 
could be used for the simultaneous determination of ee and total concentration.33 
Because the tryptophanol based self-assembly reflects both the diol concentration and the 
change in ee value of the respective enantiomers, both can be calculated in conjunction with a 
supervised pattern recognition method Artificial Neural Networks (ANNs) to analyze the data. 23,43 
A general approach for creating HTS assays for the determination of ee and total concentration 
(yield) should meet certain basic criteria. First, the receptor components and enantiopure reporters 
are commercially available in both enantiomeric forms. This criterion is the strength of our 
fluorescence-based approach, which is modular and thereby allows one to match commercially 
available enantiopure reporters such as BINOL, VANOL, or tryptophanol with 2-
formylphenylboronic acid and the chiral analyte enantiomers. Second, HTS platforms are widely 
available and fast and allow for the generation of a large dataset to train ANN and analyze 
unknowns for ee and total concentration if needed. Here, we used a 384-well plate for data 
collection, this plate format is significantly more rapid than in a standard bench-top fluorimeter 
cuvette measurement. Fluorescence measurements for each well in a 384 well plate is generated 
in 5 min in endpoint mode, and fluorescence data are imported into a computer containing software 
able to perform linear/nonlinear regression, LDA, or ANN resulting in simultaneous output of the 
ee and total concentration values with overall assay time of 3 hour. 
ANN utilizes a more complex and expanded calibration set that covers different total 
concentration values along with various ee (Figure 6). As a validation/”unknown” data set we used 
different concentrations of products from the Noyori asymmetric transfer hydrogenation reaction 
in our assay. ANN was employed to calculate the total concentrations and ee of the hydrobenzoin 
in the Noyori reaction mixtures. We created an expanded training set containing 15 different 
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scalemic mixtures (100, 96, 92, 80, 50, 20, 5, −5, −20, −50, −80, −92, −96, −100 % ee) and rac-
mixture, using 5 total concentrations of hydrobenzoin (5, 10, 20, 30, and 40 µM). The entire data 
set comprised 75 cases with 20 repetitions in each case (1500 experiments). Simple LDA was used 
for graphical visualization of the resulting data. The semi-quantitative LDA analysis (Figure 6) 
yielded smooth ee and concentration-specific trends in the data, clear separation of the clusters, 
and 100% correct classification of scalemic mixtures as well as total concentrations of these 
analytes. Figure 6 shows the 2D representation of the LDA output defined by the first factor (F1) 
vs. ee values and comprised 100% of total variance. Five clearly resolved ee-dependent trends are 
very well distributed in the response space of LDA, and concentration dependence encoded by the 
magnitude of the F1 score for each trend. As expected, the amplitude of distribution for ee-
calibration plot with the total concentration of 40µM (green in Figure 6) is 13 times larger than the 
amplitude for the set with 5µM total concentration (red in Figure 6).  
 
Figure 6. LDA output representation of the expanded calibration data set using L-TrpOH/FPBA sensors 
assembly. Left: Calibration plot comprised various scalemic mixtures of hydrobenzoin at five different total 
concentrations (5 µM, 10 µM, 20 µM, 30 µM, and 40 µM). The response space is defined by the first factor (F1) of 
LDA vs. ee values comprising 100% of total variances. Data represented as canonical scores of group means. 
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Measurements were made at room temperature with 20 repetitions for each mixture. Each data point is shown on the 
graph as an average value computed from 20 independent measurements (repetitions). Graphical representations of 
the variability of data shown on graphs as the error bars to indicate the standard deviation in the reported measurement. 
Right: Due to coefficient of variation (CV) being below 4% for all performed experiments, the error bar for most data 
points is located within the corresponding mean point on the graph. Graphs are fitted with a linear fit equation. 
Fluorescence responses for different concentrations and ee values of the hydrobenzoin were 
obtained in the form of guest concentration and specific ee (X) × variable (Y) matrix, and first 
used as a training set to train an ANN. An Artificial Neural Network program automatically 
generates several neural networks that give in outputs the total guest concentration and ee of the 
hydrobenzoin for Noyori asymmetric hydrogenation reaction mixtures. 
 
LIMITATIONS OF THE METHOD 
All high-throughput fluorescence-based assays have fundamental limitations. They require high-
precision liquid handling robotics. Also, fluorescence intensity changes may be environmentally 
sensitive (solvents, additives), potentially limiting the use of this methods. We have addressed this 
in part by suggesting that the user increase concentration of tested sample solution up to 80 mM 
(if possible) if interfering compounds such as solvents, inactive catalysts, crude reaction mixture 
components or any other possible additives are present (see Procedure 1, Step 2). This will 
decrease a volume of an analyte added to the receptor-premix and also decrease an effect of 
possible interfering impurities. Having said this, we have found that for all reactions tested so far, 
the inactive catalyst, formic acid, triethylamine, and benzils have not had any effect on complex 




Figure 7. Example of small and big Δ between diastereomeric complexes assembled with opposite enantiomers 
of chiral analyte at the same final concentration 40 μM. Fluorescence spectra of L-tryptophanol - FPBA (1:1, 40 
μM) with Right: Hydrobenzoin enantiomers (40 μM) in MeCN. λex = 280 nm. Left: Phenylethylene glycol enantiomers. 
Δ diastereomers for hydrobenzoin is bigger than Δ diastereomers for phenylethylene glycol, which suggests simpler 
ee determination of hydrobenzoin, in comparison to phenylethylene glycol.  
Calibrating a standard curve for products of asymmetric reaction can also be challenging, due to 
possible formation of meso form of chiral analytes which is also able to facilitate the complex 
assembly and contribute in overall system fluorescence response (false positive response). Another 
concern relevant to fluorescence-based assays is the small Δ (difference in emission intensity 
shown on Figure 7) of diastereomers at 1:1:1 stoichiometric ratio of assembly components (Figure 
7). In other words, this occurs when the diastereomeric complexes assembled with opposite 
enantiomers of the analyte have a similar fluorescence intensity (Δ is small) at the same 
concentration (Figure 7, right), making it difficult to accurately measure the effect of ee on the 
fluorescence change. This potential issue can be overcome by combining several ligands that each 
have a different degree of sensitivity for each analyte to expand the information density of the 
array-protocol and improve its discriminatory power. This can lead to the generation of a large 
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multi-dimensional response space and improved resolution of the array but will require using 
statistical methods such as linear discriminant analysis (LDA) or support vector machine 
regression analysis (SVM). 
Biocatalysts are widely used in industry in the production of enantiopure drugs and as well for the 
synthesis of complex chiral compounds in academic research.44 The development of a biocatalyst 
involves iterative screening of potential enzymes and it would be very tempting to use the protocol 
as written here for this type of high throughput screening. . Unfortunately, it is necessary to use 
different reagents. This is because key classes of biocatalysts including many enzymes such as 
isomerases, hydrolases, lyases, oxidases, and reductases will absorb in the same region as 
tryptophanol (280-285 nm) due to the presence of tryptophan. Also, their emission (330-360 nm) 
can overlap with the emission of BINOL and VANOL. To overcome this issue, for enzymatic 
reactions screening the reporter (BINOL, VANOL, or tryptophanol) should be replaced with 
fluorescent amino acids (FlAAs) or diol ligands which will have red shift of absorption/emission 
spectra. Several amino acid derivatives of pyrene (λem=375 nm), 6-(2-dimethylaminonaphthoyl) 
alanine (DANA) (390 \ 450-550 nm)45, as well as commercially available α-Dansyl-L-arginine 
hydrochloride or BINOL derivative (R)\(S)-3,3′-Di-9-phenanthrenyl-1,1′-bi-2-naphthol have 
absorption\emission profiles that don’t overlap with enzymes. When adapting this procedure such 
that the alternative reagents (different fluorophores) are used, it is necessary to perform complex 
optimization to confirm optimum conditions (reagent equivalent ratio, concentration, and 
equilibration time) for assembly formation. Reagents solubility and specific assembly-enzyme 
interactions are another key factor which must be determined during optimization. Optimization 
step involves a fair amount of work, yet ultimately can be done in an automated way using 384 
well plates, robotic liquid handler, and microplate reader suitable for fluorescence measurement. 
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Acquiring this information would require several fluorescence titrations or perform an initial 
screening directly in a 96-well screening plate as now described. A screening plate can be designed 
to determine which chiral fluorescent host and complex concentration shows the best 
discrimination between the 2 enantiomers of desired chiral analyte. 
Fluorescence titrations can be performed to explore different chiral host scaffolds, such as 
described above, and 2-formylphenylboronic acid. Fluorescence titration profiles can be created 
with one equivalent of FlAAs or fluorescent chiral diol ligands self-assembled with one equivalent 
of 2-formylphenylboronic acid at the suggested starting concentration of 40 µM and upon the 
addition of incremental amounts of chiral analyte. It is recommended to reach a plateau of the 1:1 
binding isotherm in order determined correct complex stoichiometry. For fluorescence titration the 
reagent that generates the fluorescent signal should be kept at a constant concentration throughout 
the experiment to avoid signal changes due to changes in the concentration. The bandwidth settings 
on the fluorescence spectrometer depend strongly on the quantum yield of the fluorophore but 
recommended to keep as narrow as possible to attain enough signal. If the observed fluorescence 
intensity is low the emission bandwidth must be increased. Also, the excitation bandwidth can be 
reduced If fluorescence bleaching is observed during the titration experiment. The concentration 
can be adjusted according to the sensitivity of the spectrometer and the Ka value of the interaction 
that is being analyzed. 
STATISTICAL ANALYSIS 
The response patterns associated with fluorescence-based assays (using several fluorescence 
channels, or combined data from BINOL and VANOL-receptor complexes) are acquired in a form 
of multivariate data set. Hence, chemometric pattern recognition techniques such as supervised 
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methods including linear discriminant analysis (LDA) and support vector machine (SVM) 
regression analysis can be used to identify the samples and generate a classification model that can 
later be used to assign the unknown samples  
Data pre-treatment. The first steps prior to the application of multivariate data analysis 
techniques are variable selection/reduction and data pre-treatment.46, For this purpose, 
conventional manual analyses as well as robust statistical methods such as Student’s T-test can be 
utilized in order to examine the difference (standard deviation) between data within the set of 
repetitions for each sample and exclude outlying data points from variables containing noisy 
information.  
Linear Discriminant Analysis (LDA). LDA is the most frequently used supervised pattern 
recognition method for reduction of dimensionality and classification of the multivariate data. 
LDA is based on the determination of linear discriminant functions (DF) that aim to maximize the 
ratio of between-class variance while minimizing the ratio of within-class variance. First, LDA 
develops a model with part of data set (training set) which describes the relationship between the 
observed variables and their known classes. After that, the model is tested for its recognition 
(classification) ability using another part of the data (test set). Both, training and test sets contain 
data representative of each class. This procedure, consisting of a model development and model 
testing, is repeated several times. The latter process is called cross-validation.47 The most common 
cross-validation approach is the so-called leave-one-out cross-validation which removes only one 
sample at a time from the training set and considers it as a test set.48 The procedure is repeated 
until all samples have been left out and classified. This way, the data of unknown identity can be 
later assigned to one of the classes based on the similarity of its responses to the responses of the 
samples in the training set. Thus, the predictive power of an array can be determined.  
26 
 
LDA reduces the dimensionality of the data set by calculating the eigenvalues which are correlated 
with factors and factor scores (coordinates of the observations in the new space of reduced 
dimensionality). The magnitude of eigenvalues represents the variance in the data. The first factor 
(F1) accounts for the most variance in the data, and the other factors follow in the order of 
decreasing variance.  
Support Vector Machine (SVM). For nonlinear quantitative analysis of the enantiomeric 
mixtures with small Δ, a supervised method such as support vector machine (SVM) is a very 
reliable method, especially when dealing with data sets containing several distinct classes that 
cannot be easily separated by linear boundaries.49 The goal of SVM is to obtain the “optimal” 
boundaries which separates the analyte classes. This is achieved by using kernel functions, which 
consist of transformation of the nonlinear data set into an n-dimensional vector space where the 
classes can be separated linearly.50 
Then, the recognition ability of the model is usually tested using n-fold cross-validation approach. 
Thus, each instance of the whole training set is predicted once and the cross-validation accuracy 
is the percentage of the data which were correctly classified. Based on kernel functions, the SVM 
generates the regression (calibration) model. First, the training set is used to calibrate the model 
producing the root mean square error of calibration (RMSEC). Then, the model is validated using 
n-fold cross-validation approach producing the root mean square error of cross-validation 
(RMSECV).51 Finally, the validity and predictive ability of the developed model is tested using 
independent data set (unknown samples). The predictive accuracy of a model can be evaluated by 
the value of the root mean square error of prediction (RMSEP).  
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Artificial Neural Network (ANN). Fluorescence-based protocol for HTS of ee and total 
concentration (reaction yield) of chiral analytes (amines or diols) relies on using ANN as the data 
analysis tool for simultaneous prediction of both parameters and can be used in the case when Δ 
is small. Most of Neural Networks software have an embedded intelligent problem solver (IPS) 
function, which automatically generates several neural networks that are suitable for the selected 
problem. The ability to self-teach and to model complex nonlinear data are the main advantages 
of ANN-based protocol. In the literature there are many types of artificial neural networks 
available for different applications. The simplest and the most frequently used type of neural 
network is the multilayered perceptron (MLP) with a feed-forward topology. The most important 
part of the MLP-ANN is the training step. The training (ANN learning step) is a search procedure 
for a set of weight values with the main task of minimizing the squared errors of prediction 
(experimental vs estimated data). Among variety of learning algorithms for MLP (conjugate 
gradient descent, quasi-Newton, etc.,) we recommend using the most employed one - the back-
propagation algorithm. The back-propagation algorithm uses the output or prediction layer’s error 
values to adjust the weight of layer connections. Thus, his algorithm provides a guarantee of 
minimum (local or global) convergence. The main challenge of MLP-ANN is the choice of the 
most suitable architecture, because the speed and the performance of the MLP-ANN learning are 
strongly depending on the number of layers. The number of layers in MLP algorithm is directly 
proportional to the complexity of each specific problem. The higher the number of hidden layers, 
the higher the complexity of the pattern recognition of the neural network. Simple n-layered MLP 





CAUTION Inhalation of vapors or mists of toxic or corrosive chemicals can cause severe 
bronchial irritation. Many amines are highly toxic and corrosive and may causes serious eye 
damage and skin irritation if handled with standard precautions. Do not work alone when handling 
toxic chemicals. Use a fume hood to ensure proper ventilation or wear appropriate respiratory 
protection if a fume hood is not available. 
Δ CRITICAL All the reagents can be purchased from commercial suppliers and used without 
further purification. Purchase enantiopure ligands and chiral standards with enantiomeric purity 
preferably ≥ 99.0% (for chiral derivatization). 
• Enantiopure chiral diols:  
(R)-(+)-1,1′-Bi(2-naphthol) (ee ≥99% by HPLC, Aldrich, cat. no. 246948 ) 
(S)-(−)-1,1′-Bi(2-naphthol) (ee ≥99% by HPLC, Aldrich, cat. no. 246956) 
(S)-3,3′-Diphenyl-2,2′-bi(1-naphthol) (ee ≥97% by HPLC, Aldrich, cat. no. 675334) 
(R)-3,3′-Diphenyl-2,2′-bi(1-naphthol) (ee ≥97% by HPLC, Aldrich, cat. no. 675156) 
(S)-(+)-3-chloro-1,2-propanediol (ee ≥98%, TCI, cat. no. C1542) ! CAUTION 
(R)-(−)-3-chloro-1,2-propanediol (ee ≥98% (GLC), Aldrich, cat. no. 540056) ! CAUTION 
(S)-(+)-1-phenyl-1,2-ethanediol (ee ≥98%, Aldrich, cat. no. 302155)  
(R)-(−)-1-phenyl-1,2-ethanediol (ee ≥99%, Aldrich, cat. no. 302163) 
(+)-dimethyl L-tartrate (ee ≥ 99% (GLC), Aldrich, cat. no. 163457)  
(‒)-dimethyl D-tartrate(ee ≥99% (GLC), Aldrich, cat. no. 242942) 
(+)-diethyl L-tartrate (ee ≥99% (GLC), Aldrich, cat. no. 156841)  
(‒)-diethyl D-tartrate (ee ≥99% (GLC), Aldrich, cat. no. 213969) 
(1S,2S,3R,5S)-(+)-pinanediol (ee 99% (GLC), Aldrich, cat. no. 282367) 
(1R,2R,3S,5R)-(‒)-pinanediol (ee 99%, Alfa Aesar, cat. no. H56580) 
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(S,S)-(‒)-hydrobenzoin (ee 99% (GLC), Aldrich, cat. no. 256269) 
meso-hydrobenzoin (Aldrich, cat. no. 294535) 
(R,R)-(+)-hydrobenzoin (ee 99% (GLC), Aldrich, cat. no. 256277) 
(3S,5S)-atorvastatin calcium (ee ≥99%, USP, cat. no. 1044571) 
(3R,5R)-atorvastatin sodium (ee ≥99%, TRC, cat. no. A791730) 
• 2-Formylphenylboronic acid (Aldrich, cat. no. 431958)  
• Enantiopure chiral amines: 
(S)-(−)-α-Methylbenzylamine (ee ≥ 99.0%, Sigma-Aldrich, cat. no. 77869) ! CAUTION  
(R)-(+)-α-Methylbenzylamine (ee ≥ 99.0%, Sigma-Aldrich, cat. no. 77879) ! CAUTION  
(R)-(+)-β-Methylphenethylamine (ee 99.0%, Aldrich, cat. no. 461385) ! CAUTION  
(S)-(−)-β-Methylphenethylamine (ee 99.0%, Aldrich, cat. no. 461393) ! CAUTION  
(S)-(−)-1-(2-Naphthyl)ethylamine (ee ≥ 99.0%, Aldrich, cat. no. 70942) ! CAUTION  
(R)-(+)-1-(2-Naphthyl)ethylamine (ee ≥ 99.5%, Sigma-Aldrich, cat. no. 70710) ! CAUTION 
(S)-(+)-2-Aminobutane (ee 99.0%, Aldrich, cat. no. 296651) ! CAUTION  
(R)-(−)-2-Aminobutane (ee 99.0%, Aldrich, cat. no. 296643) ! CAUTION  
• Chiral amino alcohols: 
(S)-(−)-2-Amino-3-phenyl-1-propanol (ee 99.0% (HPLC), Aldrich, cat. no. 190438) ! CAUTION 
(R)-(+)-2-Amino-3-phenyl-1-propanol (ee 99.0%, Aldrich, cat. no. 284491) ! CAUTION (1S,2R)-
(−)-cis-1-Amino-2-indanol (ee: 99% by GLC, Aldrich, cat. no. 440833) ! CAUTION 
(1R,2S)-(+)-cis-1-Amino-2-indanol (ee: 99% by GLC, Aldrich, cat. no. 440841) ! CAUTION 
L-Tryptophanol (Aldrich, cat. no. 469971) 
D-Tryptophanol (Aldrich, cat. no. 470031) 
• Chiral amino acid esters.  
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L-Valine methyl ester hydrochloride (ee 99% Aldrich, cat. no. 860271) 
D-Valine methyl ester hydrochloride (ee ≥99.0% (AT), Aldrich, cat. no. 94665)  
L-Phenylalanine methyl ester hydrochloride (ee ≥99.0%, Alfa Aesar, cat. no. A11455) 
D-Phenylalanine methyl ester hydrochloride (ee ≥99.0%, Alfa Aesar, cat. no. H25920).  
L-Methionine methyl ester hydrochloride (ee ≥99.0%, Chem-Impex International, Inc. cat. no. 
03105)  
D-Methionine methyl ester hydrochloride (ee ≥99.0%, Chem-Impex International, Inc. cat. no. 
03106)  
L-Alanine methyl ester hydrochloride (ee ≥99.0%, Chem-Impex International, Inc. cat. no. 02890)  
D-Alanine methyl ester hydrochloride (ee ≥99.0%, Chem-Impex International, Inc. cat. no. 
03016).  
L-Tryptophan methyl ester hydrochloride (ee ≥99.0%, Chem-Impex International, Inc. cat. no. 
03152) 
D-Tryptophan methyl ester hydrochloride (ee ≥99.0%, Chem-Impex International, Inc. cat. no. 
04454) 
• Solvents.  
Propionitrile (optional, Aldrich, cat. no. 185590) 
Acetonitrile (anhydrous, 99.8%, Sigma-Aldrich, cat. no. 271004) 
Phosphorus pentoxide (optional, Sigma-Aldrich, cat. no. 298220) 
• Cesium carbonate (optional, Aldrich, cat. no. 441902) 
• Sodium bicarbonate (optional, Sigma-Aldrich, anhydrous, free-flowing, Redi-Dri™, ACS 
reagent, ≥99.7%, cat. no. 792519) 
• Chloroform (optional, EMD MILLIPORE, cat. no. CX1050) 
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• Magnesium sulfate (optional, Sigma-Aldrich, anhydrous, ReagentPlus®, ≥99.5%, cat. no. 
M7506) 
• Molecular sieves, 4 Å (beads, 4-8 mesh, Sigma-Aldrich, cat. no. 208590) 
• Sodium citrate (optional, USP, cat. no. 1613859) 
EQUIPMENT 
• Rotavapor (R-100 System, Buchi, cat. no. 11100V2112) 
• Glass separatory funnel, 50 mL (Aldrich, cat. no. Z548014) 
• Glass round-bottom flask, 50 mL (Aldrich, cat. no. Z510416) 
• Microplate reader (CLARIOstar multi-mode microplate reader (BMG LABTECH)) 
• Benchtop Centrifuges (Beckman Coulter Allegra X-30 Series, S6096 microplate rotor) 
• Adjustable Volume Pipette, 0.1-1.0 µl (Accuris™ NextPette™, LPS, cat. no. P7700-1) 
• Adjustable Volume Pipette, 0.5-10 µl (Accuris™ NextPette™, LPS, cat. no. P7700-10) 
• Adjustable Volume Pipette, 10-100 µl (Accuris™ NextPette™, LPS, cat. no. P7700-100) 
• Adjustable Volume Pipette, 100-1000 µl (Accuris™ NextPette™, LPS, cat. no. P7700-
1000) 
• Non-filtered pipette tips, 12.5 µL (Thermo Scientific™, cat. no. 94410050) 
• Filter pipette tips, 200 µL (Thermo Scientific™, cat. no. 94300130) 
• Filter pipette tips, 1000 µL (Thermo Scientific™, cat. no. 94300220) 
• Amber Borosilicate Screw Thread Vials with Green PP Hole Cap & PTFE/Silicone Septa, 
20 mL (VWR, cat. no. 36319-408) 
• 384 well density microplates (Aurora Microplates, part# ABC010100A) 
• Liquid handling system (16-channel Nanodrop Express, BioNex Solution Inc.) 
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• BNX 1536™ liquid handling system  
• Eppendorf Safe-Lock tubes, 0.5 mL (SIGMA, cat. no. T8911) 
• Eppendorf Thermomixer R 
• A graphing program that enables to perform linear/nonlinear regression analysis. We have 
used Microsoft Excel, Origin (OriginLab), SOLO (Eigenvector Research, Inc.), STATISTICA 
Automated Neural Networks (SANN). 
REAGENT SETUP 
Parent amines In the case that amine is available only as their corresponding hydrochloride (HCl 
salt), in order to obtain the free amine in acetonitrile, 1.0 equivalent of anhydrous Cs2CO3 has to 
be added and stirred for 60 minutes. The solid suspension then has to be filtered through syringe 
filters (diameter: 4mm; membrane: nylon; pore size: 0.2µm). 
 
Amino acid esters Prepare these using the liquid/liquid extraction procedure as described below.  
1) Spike 1 ml of an aqueous sample with enantiopure amino acid ester hydrochloride at a 
concentration of 1g/ml, and 3 ml of sodium bicarbonate (NaHCO3, saturated aqueous 
solution).  
2) Add 5 ml of H2O and 20 ml of chloroform in a 50 ml separation funnel. Collect the organic 
phase and repeat same procedure 2 more times.  
3) Dry the collected organic phase over MgSO4 and filter. Then transfer the organic layer into 
a clean round-bottom flask and evaporate chloroform to dryness on a rotary evaporator. Δ 
CRITICAL We recommend leaving the dry residue under vacuum at room temperature (≈ 




Round-bottom flask Dry a 50 mL glass round-bottom flask by placing it for at least 1 hour in 
an oven set at 120 °C 
Liquid-handling dispensing device Set up liquid-handling dispensing devices for a pipetting 
the 384 well density plates format as outlined in the manufacturer’s guidelines for steps 10 of 
Procedure 1  and Step 13 of Procedure 2.  
Plate reader Turn on the plate reader as outlined in the manufacturer’s guidelines.  
If you are using the BMG CLARIOstar, use these instrument settings: 
Detection Mode Fluorescence Intensity-Emission 
Method Top optics 
Optic settings Monochromator presets will depend on the 
enantiopure dye-receptor premix pair. 
No. of flashes 40 
Focus and Gain Need to be adjusted for your particular 
instrument to reduce signal-to-noise ratio. 
Adjustment must be set by using standards 
well. Enantiopure L-Tryptophanol dye-
receptor premix pair shows strong 
amplification of the fluorescence signal, so 
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the adjustment must be set by using S1 and 
S16 (-100% ee and +100% ee) wells to avoid 
saturation of the detector. 
 
 

















BINOL 335 355 8 8 349.5 
VANOL 335 375 8 10 363.8 
Monochromator presets for the enantiopure L-Tryptophanol dye-receptor premix: 





















Δ CRITICAL Each standard for the calibration curve should be prepared separately and in a same 
manner as analyzed/validation/unknown samples (i.e. according to the procedure described in 
Steps 2-6 of the Procedure 1 and Steps 3-5 of the Procedure 2). The number of standards strongly 
depends on Δ i.e. the signal difference between final diastereomers formed with opposite 
enantiomers of standard and sensitivity of the plate reader. If the signal Δ between final 
diastereomers of a standard is relatively low and gives small room for ee resolution, we recommend 
using two receptor-premixes (BINOL:2-FPBA and VANOL:2-FPBA) to add more read-out 
channels and increase informational density of the assay. We also recommend increasing the 
number of standards to improve the quality of the calibration model and increase its prediction 
capability. 
Use 8.8 mM stock solution of enantiopure fluorescent diol-ligand to reach a final concentration of 
receptor-premix (4 mM BINOL : 2-FPBA) with a slight excess of chiral diol presented in the 
system, to ensure the completion of the complexation reaction for standards and 
analyzed/unknown samples, 
The procedure is divided into 2 sections: Procedure 1) simple assay for determination of 
enantiomeric purity of chiral amines, amino alcohols, amino acid esters, diols and sugars (steps 1-
14); Procedure 2) assay for simultaneous determination of ee and total concentration (yield) with 




PROCEDURE 1: simple assay for determination of enantiomeric purity of chiral amines, 
amino alcohols, amino acid esters, diols and sugars 
Samples Preparation ● TIMING 3.5 hours 
1| While the method for preparing the working solutions is very similar, there are a few minor 
differences depending on whether you are analyzing Chiral Amines, Amino Alcohols, and Amino 
acid esters (option A) or Chiral Diols and Sugars (option B). 
A Solutions for Analyzing Chiral Amines, Amino Alcohols, and Amino acid esters ● 
TIMING 25-30 min 
 
i. Prepare 10 mL of 8.8 mM stock solution of BINOL. Weigh out 25.2 mg (0.088 mmol) 
of (S)-BINOL (MW=286.32) and transfer to the amber borosilicate screw thread 20 mL 
vial.  
ii. Transfer 10 mL of acetonitrile to the vial from previous step using a 100-1000 µl adjustable 
volume pipette with disposable tips. 
iii. Prepare 10 mL of 8.8 mM stock solution of VANOL. Weigh out 38.6 mg (0.088 mmol) 
of (S)-VANOL (MW=438.52) and transfer this to the amber borosilicate screw thread 20 
mL vial.  
iv. Transfer 10 mL of acetonitrile to the vial from previous step using a 100-1000 µl adjustable 
volume pipette with disposable tips. 
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v. Prepare 10 mL of 8.0 mM stock solution of 2-formylphenylboronic acid. Weigh out 
12.0 mg (0.080 mmol) of 2-formylphenylboronic acid (MW=149.94) and transfer to the 
suitable 20 mL vial. 
vi. Transfer 10 mL of acetonitrile to the vial from previous step using a 100-1000 µl adjustable 
volume pipette with disposable tips. 
vii. Prepare the mixture. Mix 10 mL of fluorescent chiral diol-dye and 10 mL of 2-
formylphenylboronic acid stock solutions in the amber borosilicate screw thread 20 mL 
vial. Stir ≈ 10 min until a homogeneous 4mM receptor-premix solution is obtained. See 
step 2 to continue. 
□ PAUSE POINT The resulting 4 mM receptor-premix solution is stable to moisture and can be 
handled without the need to operate in an inert atmosphere. At this step premix can be left 
overnight. 
B Simple Assay for Chiral Diols and Sugars ● TIMING 25-30 min 
<CRITICAL> To ensure the completion of the complexation reaction for standards and 
unknown samples, mix 1.1:1 equiv. ratio from 8.8 mM stock solutions of enantiopure L-
tryptophanol-dye with 8.0 mM stock solutions of 2-formylphenylboronic acid (FPBA) to achieve 
final concentration of receptor-premix 4 mM in acetonitrile with a slight excess (1.1 equiv.) of L-
tryptophanol-dye.  
i. Prepare 10 mL of 8.8 mM stock solution of L-tryptophanol. Weigh out 16.74 mg 
(0.088 mmol) of L-tryptophanol (MW=190.24) and transfer to the amber borosilicate 
screw thread 20 mL vial.  
38 
 
ii. Transfer 10 mL of acetonitrile to the vial from previous step using a 100-1000 µl 
adjustable volume pipette with disposable tips. 
iii. Prepare 10 mL of 8.0 mM stock solution of 2-formylphenylboronic acid. Weigh 
out 12.0 mg (0.080 mmol) of (MW=149.94) and transfer to the suitable 20 mL vial. 
iv. Transfer 10 mL of acetonitrile to the vial from previous step using a 100-1000 µl 
adjustable volume pipette with disposable tips. 
v. Prepare the mixture. Mix 10 mL of enantiopure L-tryptophanol-dye and 10 mL of 2-
formylphenylboronic acid stock solutions in the amber borosilicate screw thread vial. 
Stir ≈ 10 min until a homogeneous 4mM receptor-premix solution is obtained.  
□ PAUSE POINT The resulting 4 mM receptor-premix solution is stable to moisture and can be 
handled without the need to operate in an inert atmosphere. At this step premix can be left 
overnight. 
Addition of the component under analysis. ● TIMING 2 hours 
<CRITICAL> A three-component condensation reaction proceeds to completion only in a 
presence of 1.1 equiv. of the enantiopure fluorescent dye (S-BINOL/S-VANOL for amines, or L-
tryptophanol for diols), 1 equiv. of 2-formylphenylboronic acid and 1 equiv. of amine/amine 
derivative, or diol to be tested. We recommend preparing 2 mL concentrated stock solutions of 
enantiopure analytes to ensure integrity of the assay. 
2| Prepare concentrated stock solutions (2 mL) of enantiopure analytes in acetonitrile: 
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For amine/amine derivative assay Two opposite enantiomers of the chiral amine/amine 
derivative to make suitable number of standards (16 in this 
procedure) for calibration.  
Amine/amine derivative samples to be analyzed. 
For diol assay Sufficient quantities of each enantiomer of the appropriate 
diols to make the number of standards needed for 
calibration (16 in this procedure).  
Diol samples to be analyzed 
 
Δ CRITICAL STEP The concentration of the chiral analytes stock solutions strongly depends on 
the solubility and the purity of the tested system. We recommend using 40 mM stocks, but increase 
concentration up to 80 mM (if possible) if interfering compounds such as ethylene glycol, inactive 
catalysts, crude reaction mixture components or any other possible additives are present in the 
tested samples. 
 ? TROUBLESHOOTING 
3| Transfer in to 0.5 mL Eppendorf tubes appropriate amounts of receptor-premix solution 
(X, mL) of enantiopure dye with 2-formylphenylboronic acid using following equation: 
X mL+Yn mL = 0.2 mL 
Yn = YR+YS, so that  
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X mL+(YR+YS mL)n = 0.2 mL 
Assuming that the reactions are being done with all the reagents at 4 mM, then: 
X is the volume of the 4 mM receptor-premix solution of enantiopure dye and 2-
formylphenylboronic acid, mL 
Yn – 4 mM, corresponding total volume of analyzed amine/amine derivative, or diol stock solution 
for all n number of measured standards tested samples, mL. 
4| Prepare (n) number of standards at 1.1:1:1 ratio (1.1:1 equiv. is a receptor-premix, and 1 
equiv. of tested chiral amine/amine derivative, or diol) which will cover desired range of 
enantiomeric compositions (See Table 2 for suggested standards ee range). Combine different 
volumes of stock solutions of enantiopure amine/amine derivative, or diol enantiomers (YR and 
YS, mL) in order to reach a total concentration 4 mM (1 equiv.) in a Yn = 20 µL (for 40 mM stocks) 
total volume or 10 µL (for 80 mM stocks). Δ CRITICAL STEP We recommend covering range 
from -100% (pure S-enantiomer) to +100% (pure R-enantiomer). 
Table 2 Preparation of Yn = YR+YS (µL) for standards with different enantiomeric composition. 
n ee% %R %S YR, µL YS, µL Yn, µL 
S1 100 100 0 20.0 0.0 20.0 
S2 95 97.5 2.5 19.5 0.5 20.0 
S3 90 95 5 19.0 1.0 20.0 
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S4 80 90 10 18.0 2.0 20.0 
S5 60 80 20 16.0 4.0 20.0 
S6 30 65 35 13.0 7.0 20.0 
S7 10 55 45 11.0 9.0 20.0 
S8 0 50 50 10.0 10.0 20.0 
S9 -10 45 55 9.0 11.0 20.0 
S10 -20 40 60 8.0 12.0 20.0 
S11 -40 30 70 6.0 14.0 20.0 
S12 -60 20 80 4.0 16.0 20.0 
S13 -80 10 90 2.0 18.0 20.0 
S14 -90 5 95 1.0 19.0 20.0 
S15 -95 2.5 97.5 0.5 19.5 20.0 
S16 -100 0 100 0.0 20.0 20.0 
Δ CRITICAL Total volume and concentration of added chiral amine/amine derivative Yn = YR+YS 
must be Yn = 0.02 mL and 4 mM (1 equivalent) respectively for all n number of standards and 
analyzed unknown samples. 
42 
 
5| Add Yn, mL of YR+YS into n number of 0.5 mL Eppendorf tubes previously filled with X 
mL of receptor-premix solution in an Eppendorf tube rack. 
6| Incubate the reaction mixtures for 10 min at room temperature (23 °C) to ensure the 
complexation of diastereomeric imino/oxazolidine-boronate esters. 
□ PAUSE POINT These reaction mixtures can be stored at room temperature overnight. 
Distribution of samples  
7| Design your pipetting plate layout. An example for one receptor-premix is shown in Figure 
8. Each sample must be performed in at least 8 repetitions to generate acceptable (statistically 




Figure 8. Example of pipetting plate layout in a simple assay for determination of enantiomeric purity of chiral 
amines, amino alcohols, amino acid esters, diols and sugars using one receptor-premix. “B” is a blank 
(acetonitrile); “Ctr” is a control receptor-premix solution(fluorescent ligand : 2-FPBA at 1.1:1 molar ratio with total 
concentration 4 mM); “S1-S16” are standards 1-16; * - samples with unknown ee. 
Δ CRITICAL STEP The first column (B) should be set for blanking. If you need to use two 
receptor-premix solutions (BINOL and VANOL-based) in order to get the required assay 
resolution, use the expanded layout shown at Figure 8 (Ctr and S1-S16). Do not pipet a second set 
of Blanks for expanded layout. We recommend designing the layout in a way that Ctr, standards, 
and samples under analysis with one receptor-premix placed and measured in a same plate for 
assay integrity.   
Pipetting the reagents ● TIMING 5 min 
8| The standards, samples with unknown ee and acetonitrile for control should be dispensed 
with high-precision pipetting system, and diluted 100 times with acetonitrile to 0.04 mM working 
concentration. ! CAUTION Acetonitrile is a volatile solvent. Δ CRITICAL STEP We recommend 
dispensing solvent first, due to low volume of dispensed samples and volatility of acetonitrile. 
Solvent for dilution Dispense 99 µL to each well, including Blank 
(B) wells 
Control dispense 1 µL of receptor-premix solution to 
Control (Ctr) wells 
Standards dispense 1 µL of each of the sixteen standards 
(S1-S16) in repetitions to appropriate wells 
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Chiral amines/amine derivatives, or diol 
samples to be analyzed 
dispense 1 µL in repetitions to appropriate 
wells 
 
Incubating the plate ● TIMING 2min 
9| Cover the plate with a lid and centrifuge for 2 min at 2500 rpm (T = 294 K).  
Δ CRITICAL STEP  The plate must be analyzed immediately after centrifugation due to 
volatility of acetonitrile, to reduce the microplate edge effect. The “edge effect” is a discrepancy 
between the center and outer wells and caused by evaporation. It is a very real phenomenon and 
can greatly impact your assay results. Due to the extremely low volumes the 384- and 1536-well 
microplates may experience a more expressed “edge effect”. 
? TROUBLESHOOTING 
Reading the Plate ● TIMING 5 min in the end point mode. 
10| Transfer the plate prepared in previous step to the plate reader. Record the fluorescence 
intensity at the maximum wavelength. Δ CRITICAL STEP  Make sure that your plate reader has 
subtracted the fluorescence of the blank wells (fluorescence of the plate and solvent) from the 
fluorescence readings of the rest of the plate. ? TROUBLESHOOTING 
Data Analysis ● TIMING 30 min 
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<CRITICAL> Most plate readers are supplied with standard curve-fitting software protocol, 
capable of graphing the data (linear curve fit, data prediction). We recommend using this built in 
protocol otherwise refer to step 11-14 for future information. ? TROUBLESHOOTING 
11| Calculate the average fluorescence for each control, standard, and unknown sample. 
12| Plot the average fluorescence for each standard (Y-axis) versus the enantiomeric excess 
(X-axis), preferably using a graphing program that enables to perform both linear and nonlinear 
regression analysis. We have used Microsoft Excel, Origin (OriginLab), and SOLO (Eigenvector 
Research, Inc.) to obtain a good fit and data prediction. 
13| Use a linear regression model to fit the data. Δ CRITICAL STEP We recommend to use 
the linear least squares method for finding the coefficients of polynomial equations that are a 
best linear fit to a set of X,Y data corresponding to ee and FI of the standards and unknown 
samples. A polynomial equation expresses the dependent variable Y (FI) as a first-order 
polynomial in the independent variable X (ee) generate a straight line: 
Y=mX+b 
Where Y is the fluorescence intensity reading; m is the slope of the line; X is the ee; b is the X-
axis intercept. 
14| Use coefficients (m, b) to predict values of enantiomeric excess (X) for each measured 
fluorescence intensity (Y) of tested samples. In most cases, Y is a linear function of the 
parameters m and b. ? TROUBLESHOOTING 
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PROCEDURE 2 - Assay for Simultaneous Determination of ee and Total Concentration 
(Yield) with ANN. (TIMING 4.5 hours) 
Samples preparation ● TIMING 2 hours 
1| To determine ee and total concentration of the chiral products perform Steps 1-6 of the 
Procedure 1 to prepare 80 Eppendorf tubes prefilled with the appropriate receptor-premix 
solution needed to make a training set of standards for ANN in a next step.  
2| Prepare analyte enantiomers stocks at 5 different concentrations: 5 mM (for step 3a), 10 
mM (for step 3b), 20 mM (for step 3c), 30 mM (for step 3d), 40 mM (for step e) and 8 validation 
samples of various ee and total concentration (for step 3v). 
3| Prepare 80 standards (S1-80) to cover desired range of enantiomeric compositions. Table 
2 corresponds to S65-S80 in the table below. The other series have the same series of enantiomeric 
ratios, but at different analyte concentrations. 
A S1-S16 1.1:1:0.125 equiv. ratio, where 1.1:1 equiv. is a receptor-premix 
4mM, and 0.125 equiv. of tested chiral amine/amine derivative, or 
diol with total concentration of chiral analyte is 0.5 mM 
B S17-
S32 
1.1:1:0.25 equiv. ratio, where 1.1:1 equiv. is a receptor-premix 
4mM, and 0.25 equiv. of tested chiral amine/amine derivative, or 





1.1:1:0.50 equiv. ratio, where 1.1:1 equiv. is a receptor-premix 
4mM, and 0.5 equiv. of tested chiral amine/amine derivative, or diol 
with total concentration of chiral analyte is 2 mM 
D S49-
S64 
1.1:1:0.75 equiv. ratio, where 1.1:1 equiv. is a receptor-premix 
4mM, and 0.75 equiv. of tested chiral amine/amine derivative, or 
diol with total concentration of chiral analyte is 3 mM 
E S65-
S80 
1.1:1:1 equiv. ratio, where 1.1:1 equiv. is a receptor-premix 4mM, 
and 1 equiv. of tested chiral amine/amine derivative, or diol with 
total concentration of chiral analyte is 4 mM 
V V1-V8 Validation samples (artificial “unknown” samples) for ANN model 
which can consist any known equivalent ratio and total 
concentration.  
To prepare this sets of standards combine different volumes of stock solutions of enantiopure 
amine/amine derivative, or diol enantiomers (YR and YS, mL) in order to reach a desired total 
concentration in a Yn = 20 µL  
Δ CRITICAL STEP  It is important to keep Yn = 20 µL equal for entire set of training standards. 
4| Add Yn =20 µL of YR+YS into n number of 0.5 mL Eppendorf tubes prefilled with X mL 
of receptor-premix solution in an Eppendorf tube rack. 
5| Incubate the reaction mixtures for 10 min at room temperature to ensure the complexation 
of diastereomeric imino/oxazolidine-boronate esters. 
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□ PAUSE POINT These reaction mixtures can be stored at room temperature overnight. 
Distribution of samples 
6| Design a pipetting “training plate” and “analysis plate” layout. Example layouts are 
suggested in Figure 9. Prepare 4 repetitions of each sample to generate statistically meaningful 
data and to verify the results. 
 
Figure 9. Example of pipetting plate layout in an assay for simultaneous determination of ee and total 
concentration (yield) with ANN using one receptor-premix. “B” is a blank (acetonitrile); “Ctr” is a control receptor-
premix solution (fluorescent ligand : 2-FPBA at 1.1:1 molar ratio with total concentration 4 mM); S1-S80-standards 
1-80; *- samples with unknown ee. The layout for the training plate design is such that the concentration of the final 
complex would vary along each row of the plate, whereas the ee of the solution varied from 100% to −100%. 
Δ CRITICAL STEP  The first column (B) should be set for blanking, and second column set for 
control (Ctr) in both “training” and “analysis” plates to ensure integrity of the assay.  
Pipetting the reagents ● TIMING 20 min 
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<CRITICAL> In the following steps, dispense the standards, samples with unknown ee and 
concentration, and acetonitrile for negative control with high-precision pipetting system, and dilute 
100 times with acetonitrile to 0.04 mM working concentration of fluorescence reporter and 2-
formylphenylboronic acid. We recommend dispensing solvent first, due to low volume of 
dispensed samples and volatility of acetonitrile. 
! CAUTION Acetonitrile is a volatile solvent.  
7| Dispensing of the training plate  Add the solvent for dilution: dispense 99 µL 
to each well, including Blank (B) wells. 
8| Add the control solution: dispense 1 µL of receptor-premix solution to Control (Ctr) 
wells. 
9| Dispense the standards: dispense 1 µL of each of standards (S1-S80) in repetitions to 
appropriate wells. The training plate should consist of a set of 16 ee values (100, 95, 
90, 80, 60, 30, 10, 0, -10, -20, -40, -60, -80, -90, -95, and 100) %, created at 5 different 
total concentrations of analyte (5, 10, 20, 30, and 40 µM) generated a total of 80 cases. 
 
10| Dispense an analysis plate where unknown samples of varying ee and total 
concentration values need to be tested.  Solvent for dilution: dispense 99 µL to each 
well, including Blank (B) wells. 
11| Control: dispense 1 µL of receptor-premix solution to Control (Ctr) wells. 
12| Chiral amines/amine derivatives, or diol samples to be analyzed: dispense 1 µL in 




Plate incubation ● TIMING 15 min-1 hour. 
13| Perform plate incubation and reading as described in Steps 8 – 9 of the Procedure 1. If 
plate reader allows for a spectral scanning, we recommend measuring range of 345-
365nm for BINOL, 360-385 for VANOL, and 320-340 for tryptophanol with step of 2 
nm. If only one read-out channel is used in the analysis of unknown samples, the error 
in ANN prediction may be higher.  
 
ANN Data Analysis ● TIMING 2.5 hours 
<CRITICAL>  In this section, we describe how analyze unknown samples for 
concentration (reaction yield) and ee. We were using a multilayer perceptron (MLP) 
artificial neural network which is a class of feedforward ANN. MLP is multi-layer 
feed-forward neural networks where the data information flows only in the forward 
direction. Therefore, the created output of a layer is used as input for the next layer. 
MLP-ANN using multiple layers and non-linear activation and can distinguish data 
that is not linearly separable.  
 
<CRITICAL>  An MLP-ANN was generated by using the training data set 
generated in the step 13 of Procedure 2. We used TIBCO Statistica Automated Neural 
Networks software to perform this analysis, but any available software (MatLab 
artificial neural network can be used with the described parameters. Note: TIBCO 
Statistica ANN has an wizard-style Automated Network Search (ANS) which guides 
the user step-by-step through the procedure of creating different networks and 
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choosing the network with the best performance (minimizing the possibility of a 
lengthy "trial-and-error" process).  
14| Design the input layer. Use the fluorescence readouts data obtained in a Step 13 to 
construct the training set consisted of the S1 -S80 fluorescent outcomes from [λmax], 
nm from five different concentrations (0.5mM, 1mM, 2mM, 3mM, and 4 mm) of 
chiral fluorescent ligand along with 16 ee values for each concentration, giving 80 
solutions as the training set. Constructed input layer should contain the fluorescence 
values of each ee for each used assembly. Consider using multiple emission 
wavelengths (if microplate reader is suitable for scanning mode or multiple end-point 
measurements can be performed) to increase the accuracy of the analysis. Based on 
our experience with MLP neural network and these assays only the 1 emission 
wavelength [λmax] can give sufficient model for the analysis of unknown samples. Use 
this wavelength or wavelength ranges (described in step 13 of Procedure 2) to 
measure emission intensities for all used assemblies. In case of using 2 complexes 
(VANOL-based and BINOL-based assemblies) making a total of 2 (single end-point 
measurement) or number of used assemblies x number of emission wavelengths 
values for each of the 80 cases that differ in ee and total concentration. Δ CRITICAL 
STEP We recommend avoiding use of negative values because ANN does not work 
well with negative values, therefore % of single enantiomer (R-enantiomer or % of S-
enantiomer) must be used instead of ee values. Convert the predicted values of %R or 
%S by ANN into ee in a separate step after the analysis using the following 
expression for recalculation ee = (%R-50)*2, [%]. 
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15| Consider to use a multilayered perceptron (MLP) network with 80 inputs, 8 
processing units in the hidden layer, and 2 outputs (was selected for most of our 
tested cases). Perform the training of MLP-ANN  with the emission values found for 
the 80 samples of varying concentrations and ee value using back-propagation 
algorithm, which minimize the discrepancy between the input and the outputs. The 
resulting outputs of the analysis would be the  total concentration and ee. Δ 
CRITICAL STEP The number of hidden layers can be varied until the MLP-ANN 
could accurately generate the outputs from the inputs of emission values. In most 
tested cases an MLP-ANN with 3 hidden layers gave the best results, but hidden 
layers number can be increased to 10 or even 11. Consider whether to assess the 
predictive ability of the model developed by the MLP-ANN, to do that the collected 
emissions from [λmax] for “validation” samples (we used 8 validation samples shown 
as V1-V8 on Figure 9), independent of the training set can be subjected for the 
analysis. Comparison of actual ee values and concentrations vs predicted will give 
you a strong sense of the predictive potential of the developed model. We used these 
emission values as inputs in the MLP-ANN, and tested its ability to predict the 
accurate ee values and concentrations for all assays performed during development.  
16| Next, subject true unknown samples (reaction outcomes), prepared completely 
independent of the training set (samples measured in “analysis plate”) and treated 
with the same sensor array into the previously developed and validated MLP-ANN 
model (in the steps 14 and 15)to get an outcome layer with their predicted 
concentrations and %R values. Then, convert the obtained %R values predicted by 
the network to ee values using  the following formula ee = (%R-50)*2, %. Δ 
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CRITICAL STEP The ee error can be high because of a single outlier that has an ee 
error high due to measurement or the pipetting issue. By excluding the outliers with 
the Student’s T-test, the average absolute error in ee can be significantly dropped. 
The ee error can be reduced even further by using a larger training set containing 
multiple assemblies and multi-mode measurements. 
17| The time required to perform the full analysis from measurement and training, to 
validation, and to analysis by ANN, will be approximately 3 hrs of work. Consider 
that the ANN network development is a limiting step and once it has been developed 
by using a training set for a particular analyte it is becoming a very rapid prediction 
tool. The concentration and ee values of 88 unknown samples (analysis plate) will 
require ≈ 1 hour to be determined , as it take 40 min for the liquid-handler to load a 
384-well plate with the premix, and solutions of analytes, then 7 min for the 384-well 
plate measurement by the reader to record the single end-point emission value of 88 
unknown samples with four technical replicates for each sample. After these steps the 
fluorescence data from the unknown samples can be simply load to the developed 
ANN, which will predict the concentration and ee of unknowns in real time. 
18| THIS STEP IS OPTIONAL. Consider whether you data  required pretreatment, it 
is recommended only in case of insufficient data analysis results. Use common methods for data 
classification, and more specifically supervised pattern recognition methods, which clean up and 
structuring data  by finding mathematical relationships between a set of descriptive variables 
(chemical measurements) and a qualitative variable (sample identity). These methods resolve 
multivariate data by reducing their dimensionality into a number of correlated variables, called 
the principal components (or factors). Consider that any chemometrics software can be used to 
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run data pretreatment. Absolute majority of these software packages will contain a list of 
supervised methods including LDA (qualitative data analysis) and SWM (quantitative data 
analysis). We used the EigenVector Research Inc‘s SOLO software package because it provides 
point-and-click data-discovery tools including PLS, PCA coupled with SVM and many other 
multivariate and machine learning methods. SOLO offers integrated modeling guide and access 
to a large number of analysis and preprocessing techniques which we find very user friendly and 
suggest that this graphical user interface environment appropriate for novice as well as expert 
users. Note that to run these methods using any software package will request several sub-sets of 
data including: Calibration data set (observations only), Calibration data identities, Validation 
data set (observations only), Observation data identities. Dimensionality reduction outcome 
would be a new data set with a smaller number of dimensions without substantial information 




Procedure 1, Step 2  High concentration of the chiral analytes stock will decrease the 
value of Yn, in µL which will also decrease the contribution of potential impurities from 
tested samples in a final mixture with receptor-premix (200 µL) and ensure correct and 
precise measurement in further steps. 
Edge effect in Procedure 1, Step 9-10 Step 9 were the edge effect originated. Step 
10 is the step where a plate edge effect becomes evident. Evaporation causes a change in 
the concentration of assay components in the assay media (acetonitrile) between the center 
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and outer wells of the microplate. This effect results in an increase in CV values, directly 
impacting assay robustness (Z-factor).53  
To prevent edge effect:  
• Reduce assay time (amount of time fluids are stored in the well, resulting an overall 
reduction of evaporation) 
• Use a low evaporation lid and plates with evaporation barrier (a lid with 
condensation rings, and pipet the same media (acetonitrile) in a evaporation barrier 
wells) 
• Use an optically transparent plate sealing or tape. 
• In case of 1536 well plates used with working volume (≈10 µL) acetonitrile is 
deemed too volatile. We recommend using propionitrile distilled on phosphorus 
pentoxide. 
Procedure 1, Step 14  The plot of the "residuals" (which are the differences 
between the Y values in the input data and the Y values computed by the fit equation) is 
the main indicator of the fitting function suitable for particular data set. Deviations from 
linearity will be much more evident in a plot of residuals than in the calibration curve plot. 
If the residuals are randomly scattered all along the best-fit line, then it means that the 
deviations are caused by random errors such as instrument noise or by random volumetric 
or procedural errors; in that case you can use a straight line (linear) fit. Non-linear curve 
fit, such as a quadratic or cubic fit should be used if the residuals have a smooth "U"-like 
shape (the calibration curve is curved). In cases when the residual plot has "S" shape, we 
recommend using a cubic fit. 
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To reduce the volumetric error (random errors on residuals plot), recalibrate the liquid-
handling equipment. To reduce the signal reading error (R2 < 0.990), adjust the instrument 
conditions (e.g. wavelength, focal height, gain, plate type to reduce scattering) for best 
signal-to-noise ratio and average several readings of each sample or standard. 
When protocol is applied to complex asymmetric reaction samples measurement error can 
occur due to interferences that influence the measured signal (for example by producing 
their own fluorescence signal or by reducing or increasing the signal from the analyte-
complex). One way to correct for interferences is to use "matched-matrix standards", 
standard solution that are prepared to contain everything that the reaction samples contain, 
except that they have known concentrations of chiral analyte.  
● TIMING 
ROCEDURE 1. Steps 1-14: 3 hours 30 min total for assay 
Step 1A, preparation of receptor-premix for amine assay: 30 min 
Steps 1B, preparation of receptor-premix for diol assay: 30 min 
Step 2-6, preparation of standards: 2 hours 
Steps 7–8, plate layout and pipetting: 5-10 min (depending on the number of used wells 
and plate density) 
Steps 9, plate incubation: 2 min 
Step 10, fluorescence reading: 5 min per plate using end point experiment mode. 
Step 11-14, data analysis: 30 min 
PROCEDURE 2. Steps 1-18: 4 hours 30 min total for assay  
Step 1, preparation of receptor-premix for assay: 30 min 
Steps 2, preparation of stocks: 30 min 
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Steps 3-5 preparation of standards: 1 hour 
Steps 6-12, plates layout and pipetting: 20 min (for one full 384 wells “training” plate and one full 
384-wells “analysis” plate) 
Steps 13, plates incubation and reading 15 min. -1 hour. 
Plates incubation: 2 min; 
Fluorescence reading: 5 min per plate using end point experiment mode (10 min in total). 
In case of spectral scanning ≈20 min per plate (40 min in total). 
Step 14-18, ANN data analysis: 2 hour 30 min for 88 unknowns with four technical replicates in 
full 384 well “analysis plate”. 
 
ANTICIPATED RESULTS 
The anticipated results with the high-throughput fluorescence assay depend on several factors 
including the number and enantiomeric purity of calibration standards used to calibrate the model.  
To ensure precise measurement, make sure that no additional fluorescent species are present in the 
samples, otherwise overlapping fluorescent signal may occur. In such case whether negative 
control (sample containing just analyzed material without assembly-premix) can be tested during 
prescreening step or added to the training plate. For large-scale screening validation of the model, 
prior prediction with artificial samples or the “testing set” would increase the quality of 
interpolation. Testing set is generated at the same time as a standards and consist a samples of 
known ee and concentration which used as “artificial unknowns” to validate the model (actual 
values vs predicted values). A successful procedure is dependent upon accuracy in administering 
the full dispensing volume to the microplate, in a rapid and reliable manner to avoid plate edge 
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effect. Accurate plate mapping procedure is essential to determine the exact well positions of a 
384 well plate used.  
Interpreting results of this assays in most cases can be done by linear regression model fitting, but 
in case of low signal-to-noise ratio chemometric pattern recognition technique such as supervised 
linear discriminant analysis (LDA) (to reduce the dimensionality of the data into a lower 
dimensional space), can been applied to structure and improve the data separation. For the large 
number of repetitions data can be subjected to the Student’s T-test to exclude outlying data points 
from set containing noisy information in order to minimize the standard deviation between data 
within the set of repetitions for each sample. For quantitative nonlinear regression analyses a 
supervised algorithm such as support vector machine (SVM) coupled with principal component 
analysis (PCA) and partial least squares (PLS) can be applied (typical data set examples presented 
in Supplementary Information as Supplementary Data 1-4).  
Finally, the high-throughput protocol described below is based on a 384-well plate format but 
could be easily adapted to a larger density format (1536-wells) using automated liquid handlers or 
a robotic platform. If these alternatives are pursued, the times required for preparation and 
completion of the assay may differ significantly from those indicated here. 
 
CFI 





We are thankful to our colleague Prof. T. Minami who provided expertise that greatly 
assisted the research. We are also grateful to Dr. V. Brega for her assistance with parallel 
asymmetric synthesis, and Prof. S. Gozem for his help with computational modeling of 
BINOL/VAPOL self-assemblies with analytes.  
 
Author contributions statement 
E.S. and P.A. designed the protocol. E.S. performed the experiments. P.A. and T.J. 
supervised the project. All authors contributed to the writing of the manuscript.  
 
REFERENCES 
1. Parker, D. NMR determination of enantiomeric purity. Chem. Rev. 91, 1441–1457 (1991). 
2. Kelly, A. M. et al. Simple protocols for NMR analysis of the enantiomeric purity of chiral 
diols. Nat. Protoc. 3, 215–219 (2008). 
3. Kelly, A. M., Pérez-Fuertes, Y., Arimori, S., Bull, S. D. & James, T. D. Simple Protocol for NMR 
Analysis of the Enantiomeric Purity of Diols. Org. Lett. 8, 1971–1974 (2006). 
4. Yeste, S. L., Powell, M. E., Bull, S. D. & James, T. D. Simple Chiral Derivatization Protocols for 
1 H NMR and 19 F NMR Spectroscopic Analysis of the Enantiopurity of Chiral Diols. J. Org. 
Chem. 74, 427–430 (2009). 
5. Bentley, K. W., Nam, Y. G., Murphy, J. M. & Wolf, C. Chirality Sensing of Amines, Diamines, 
Amino Acids, Amino Alcohols, and α-Hydroxy Acids with a Single Probe. J. Am. Chem. Soc. 
135, 18052–18055 (2013). 
60 
 
6. Jo, H. H., Lin, C.-Y. & Anslyn, E. V. Rapid Optical Methods for Enantiomeric Excess Analysis: 
From Enantioselective Indicator Displacement Assays to Exciton-Coupled Circular 
Dichroism. Acc. Chem. Res. 47, 2212–2221 (2014). 
7. Dragu, E. A., Naubron, J.-V., Hanganu, A., Razus, A. C. & Nica, S. Absolute Configuration 
Determination of Azulenyl Diols Isolated from Asymmetric Pinacol Coupling: Chiral Azulene-
Containing Diols. Chirality 27, 826–834 (2015). 
8. Welch, C. J. Microscale chiral HPLC in support of pharmaceutical process research. Chirality 
21, 114–118 (2009). 
9. Bobbitt, D. R. & Linder, S. W. Recent advances in chiral detection for high performance 
liquid chromatography. TrAC Trends Anal. Chem. 20, 111–123 (2001). 
10. Roussel, C., Rio, A. D., Pierrot-Sanders, J., Piras, P. & Vanthuyne, N. Chiral liquid 
chromatography contribution to the determination of the absolute configuration of 
enantiomers. J. Chromatogr. A 1037, 311–328 (2004). 
11. Berova, N., Bari, L. D. & Pescitelli, G. Application of electronic circular dichroism in 
configurational and conformational analysis of organic compounds. Chem. Soc. Rev. 36, 914 
(2007). 
12. Pirkle, W. H. & Pochapsky, T. C. Considerations of chiral recognition relevant to the liquid 
chromatography separation of enantiomers. Chem. Rev. 89, 347–362 (1989). 
13. Reetz, M. T. et al. A GC-based method for high-throughput screening of enantioselective 
catalysts. Catal. Today 67, 389–396 (2001). 
14. Leung, D., Kang, S. O. & Anslyn, E. V. Rapid determination of enantiomeric excess: a focus 
on optical approaches. Chem Soc Rev 41, 448–479 (2012). 
61 
 
15. Tsukamoto, M. & Kagan, H. B. Recent Advances in the Measurement of Enantiomeric 
Excesses. Adv. Synth. Catal. 344, 453 (2002). 
16. Finn, M. G. Emerging methods for the rapid determination of enantiomeric excess. Chirality 
14, 534–540 (2002). 
17. Pu, L. Fluorescence of Organic Molecules in Chiral Recognition. Chem. Rev. 104, 1687–1716 
(2004). 
18. Kubo, Y., Maeda, S., Tokita, S. & Kubo, M. Colorimetric chiral recognition by a molecular 
sensor. Nature 382, 522–524 (1996). 
19. Kubo, Y., Hirota, N., Maeda, S. & Tokita, S. Naked-Eye Detecbox Chiral Recognition Using a 
Chromogenic Receptor. Anal. Sci. 14, 183–189 (1998). 
20. Chen, X.-X., Jiang, Y.-B. & Anslyn, E. V. A racemate-rules effect supramolecular polymer for 
ee determination of malic acid in the high ee region. Chem. Commun. 52, 12669–12671 
(2016). 
21. Fossey, J. S. et al. Rapid Determination of Enantiomeric Excess via NMR Spectroscopy: A 
Research-Informed Experiment. J. Chem. Educ. 94, 79–84 (2017). 
22. Brittain, W. D. G. et al. The Bull–James assembly as a chiral auxiliary and shift reagent in 
kinetic resolution of alkyne amines by the CuAAC reaction. Org. Biomol. Chem. 14, 10778–
10782 (2016). 
23. Shabbir, S. H., Regan, C. J. & Anslyn, E. V. A general protocol for creating high-throughput 
screening assays for reaction yield and enantiomeric excess applied to hydrobenzoin. Proc. 
Natl. Acad. Sci. 106, 10487–10492 (2009). 
62 
 
24. Thanzeel, F. Y. & Wolf, C. Substrate-Specific Amino Acid Sensing Using a Molecular D / L -
Cysteine Probe for Comprehensive Stereochemical Analysis in Aqueous Solution. Angew. 
Chem. Int. Ed. 56, 7276–7281 (2017). 
25. Bentley, K. W., Proano, D. & Wolf, C. Chirality imprinting and direct asymmetric reaction 
screening using a stereodynamic Brønsted/Lewis acid receptor. Nat. Commun. 7, 12539 
(2016). 
26. De los Santos, Z. A. & Wolf, C. Chiroptical Asymmetric Reaction Screening via 
Multicomponent Self-Assembly. J. Am. Chem. Soc. 138, 13517–13520 (2016). 
27. Bentley, K. W., Zhang, P. & Wolf, C. Miniature high-throughput chemosensing of yield, ee, 
and absolute configuration from crude reaction mixtures. Sci. Adv. 2, e1501162–e1501162 
(2016). 
28. Tickell, D. A., Lampard, E. V., Lowe, J. P., James, T. D. & Bull, S. D. A Protocol for NMR 
Analysis of the Enantiomeric Excess of Chiral Diols Using an Achiral Diboronic Acid 
Template. J. Org. Chem. 81, 6795–6799 (2016). 
29. Wu, X. et al. Induced Helical Chirality of Perylenebisimide Aggregates Allows for 
Enantiopurity Determination and Differentiation of α-Hydroxy Carboxylates by Using 
Circular Dichroism. Chem. - Eur. J. 20, 11793–11799 (2014). 
30. Tickell, D. A., Mahon, M. F., Bull, S. D. & James, T. D. A Simple Protocol for NMR Analysis of 
the Enantiomeric Purity of Chiral Hydroxylamines. Org. Lett. 15, 860–863 (2013). 
31. Shcherbakova, E. G., Minami, T., Brega, V., James, T. D. & Anzenbacher, P. Determination of 
Enantiomeric Excess in Amine Derivatives with Molecular Self-Assemblies. Angew. Chem. 
Int. Ed. 54, 7130–7133 (2015). 
63 
 
32. Shcherbakova, E. G. et al. Toward Fluorescence-Based High-Throughput Screening for 
Enantiomeric Excess in Amines and Amino Acid Derivatives. Chem. - Eur. J. 22, 10074–10080 
(2016). 
33. Shcherbakova, E. G., Brega, V., Lynch, V. M., James, T. D. & Anzenbacher, P. High-
Throughput Assay for Enantiomeric Excess Determination in 1,2- and 1,3-Diols and Direct 
Asymmetric Reaction Screening. Chem. - Eur. J. 23, 10222–10229 (2017). 
34. Pérez-Fuertes, Y. et al. Simple protocols for NMR analysis of the enantiomeric purity of 
chiral primary amines. Nat. Protoc. 3, 210–214 (2008). 
35. Pérez-Fuertes, Y. et al. Simple Protocol for NMR Analysis of the Enantiomeric Purity of 
Primary Amines. Org. Lett. 8, 609–612 (2006). 
36. Shcherbakova, E. G. et al. Supramolecular Sensors for Opiates and Their Metabolites. J. Am. 
Chem. Soc. (2017). doi:10.1021/jacs.7b06371 
37. Bao, J. et al. Synthesis, Resolution, and Determination of Absolute Configuration of a 
Vaulted 2,2‘-Binaphthol and a Vaulted 3,3‘-Biphenanthrol (VAPOL). J. Am. Chem. Soc. 118, 
3392–3405 (1996). 
38. Zhang, Y. et al. Highly Enantioselective Deracemization of Linear and Vaulted Biaryl Ligands. 
Org. Lett. 5, 1813–1816 (2003). 
39. Brussee, J. & Jansen, A. C. A. A highly stereoselective synthesis of s(-)-[1,1′-binaphthalene]-
2,2′-diol. Tetrahedron Lett. 24, 3261–3262 (1983). 
40. Shcherbakova, E. G., Minami, T., Brega, V., James, T. D. & Anzenbacher, P. Cover Picture: 
Determination of Enantiomeric Excess in Amine Derivatives with Molecular Self-Assemblies 
(Angew. Chem. Int. Ed. 24/2015). Angew. Chem. Int. Ed. 54, 6943–6943 (2015). 
64 
 
41. Galbraith, E. et al. Dynamic covalent self-assembled macrocycles prepared from 2-formyl-
aryl-boronic acids and 1,2-amino alcohols. New J Chem 33, 181–185 (2009). 
42. Wilson, A., Gasparini, G. & Matile, S. Functional systems with orthogonal dynamic covalent 
bonds. Chem Soc Rev 43, 1948–1962 (2014). 
43. Burns, J. A. & Whitesides, G. M. Feed-forward neural networks in chemistry: mathematical 
systems for classification and pattern recognition. Chem. Rev. 93, 2583–2601 (1993). 
44. Müller, M. Chemoenzymatic Synthesis of Building Blocks for Statin Side Chains. Angew. 
Chem. Int. Ed. 44, 362–365 (2005). 
45. Krueger, A. T. & Imperiali, B. Fluorescent Amino Acids: Modular Building Blocks for the 
Assembly of New Tools for Chemical Biology. ChemBioChem 14, 788–799 (2013). 
46. Berrueta, L. A., Alonso-Salces, R. M. & Héberger, K. Supervised pattern recognition in food 
analysis. J. Chromatogr. A 1158, 196–214 (2007). 
47. Varmuza, K. Introduction to multivariate statistical analysis in chemometrics. (CRC Press, 
2009). 
48. Basheer, I. . & Hajmeer, M. Artificial neural networks: fundamentals, computing, design, 
and application. J. Microbiol. Methods 43, 3–31 (2000). 
49. Vapnik, V. N. The nature of statistical learning theory. (Springer, 2000). 
50. Muller, K.-R., Mika, S., Ratsch, G., Tsuda, K. & Scholkopf, B. An introduction to kernel-based 
learning algorithms. IEEE Trans. Neural Netw. 12, 181–201 (2001). 
51. Naguib, I. A. & Darwish, H. W. Support vector regression and artificial neural network 
models for stability indicating analysis of mebeverine hydrochloride and sulpiride mixtures 
65 
 
in pharmaceutical preparation: A comparative study. Spectrochim. Acta. A. Mol. Biomol. 
Spectrosc. 86, 515–526 (2012). 
52. Schmidhuber, J. Deep learning in neural networks: An overview. Neural Netw. 61, 85–117 
(2015). 
53. High throughput screening: methods and protocols. (Humana Press, 2009). 
 
